baber/WOPTO huggingface dataset:
Patent AU-PP681098-A0 (AU)
Title: Card wire, especially for doffers and workers
IPC: D01G15/46
Filed: 1998-10-30
Abstract: Card clothing comprises a strip of profile wire having a plurality of longitudinally aligned teeth (110) with respective overhanging tips (111). The edge-face (112) of each tooth under the overhanging tip includes at least one undercut edge-segment (114) spaced along the edge-face from the tip. This undercut edge-segment increases the retention of fibres by the edge-face during carding.
Patent FI-20002358-A0 (FI)
Inventor: JUPPI KARI
IPC: D21G9/00
Filed: 2000-10-27
Abstract: The invention is directed to an apparatus for web threading in a drying section of a paper machine or the like, which apparatus comprises a cutter (22) or the like which cuts a first strip, the so called leader (24), and at least one second strip (26) from the full-width web coming to the cylinder drying section, means for directing the leader (24) from the first drying cylinder (14) onward in the drying section, means for removing the second strip (26) from the drying section, typically to a pulper, a conveyor or the like located below the drying section, means for spreading the leader to the width of the whole web, and a wetting device (68,69) for attaching the second strip to the first drying cylinder comprising members (68') for spraying water or another suitable liquid against that portion of the first drying cylinder's surface, on which it is desired that the second strip shall be attached.
Patent IL-103595-A0 (IL)
Title: 2-heterocyclicethylamine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/4965
Filed: 1992-10-29
Abstract: Compounds of formula I, <CHEM>  wherein     A represents C=C, S or O; Q represents a 5- or 6-membered unsaturated heterocyclic ring having a nitrogen atom in the position adjacent to the point of attachment, 0-3 further heteroatoms selected from N, O and S, and substituents R6 and R7;     R<1> represents H or C<5> PI 1/4  alkyl; R<2> represents H, C<5> PI 1/4  alkyl, C<7> PI 1/4  alkenyl, C<7> PI 1/4  alkynyl, C<7> PI 1/4  cycloalkyl or NH<6>CH<6>CO-; in addition, R<1> and R<2> taken together may form a C<7> PI  psi  alkylene chain; R<3> represents H, C<5> PI 1/4  alkyl, C<7> PI 1/4  alkenyl, C<7> PI 1/4  alkynyl; R4 and R5 independently represent H, OH, C<5> PI 1/4  alkoxy, C<5> PI 1/4  alkyl, halogen, trifluoromethyl or NR8R9; R6 and R7 independently represent H, OH, C<5> PI 1/4  alkoxy, C<5> PI 1/4  alkyl, halogen, trifluoromethyl, C<5> PI 1/4  hydroxyalkyl, amidino, CONH<6> or NR8R9; in addition, R6 and R7 may independently represent O when substituted on N;     R8 and R9 independently represent H or C<5> PI 1/4  alkyl;     with various provisos;     and pharmaceutically acceptable derivatives thereof; are useful as pharmaceuticals, in particular in the treatment of neurological disorders.
Patent IL-106065-A0 (IL)
Title: Synthetic peptides for the treatment of myasthenia gravis and compositions comprising them
IPC: C07K7/08
Filed: 1993-06-18
Abstract: Peptides having at least nine amino acid residues each including an amino acid sequence which corresponds to position p200-208 or p262-266 of the human acetylcholine receptor (alpha)-subunit, but differing therefrom by one or more amino acid substitutions, are disclosed. These peptides inhibit the proliferative response of human peripheral blood lymphocytes to the myasthogenic peptides p195-212 and p259-271 and are suitable for treatment of subjects afflicted with myasthenia gravis.
Patent IL-109812-A0 (IL)
Title: Electrochemical metal analysis
IPC: G01N27/333
Filed: 1994-05-27
Abstract: PCT No. PCT/GB94/01167 Sec. 371 Date Sep. 8, 1995 Sec. 102(e) Date Sep. 8, 1995 PCT Filed May 27, 1994 PCT Pub. No. WO94/28401 PCT Pub. Date Dec. 8, 1994Electrochemical heavy metal analysis includes a printed electrode having a layer of a mercury compound or salt supported thereon. The compound or salt is reduced to metallic mercury in use of the electrode. The mercury layer may comprise a layer of hydroxyethyl cellulose or other permeable polymer.
Patent IL-111258-A0 (IL)
Title: Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IPC: A61K31/55
Filed: 1994-10-12
Abstract: A method of inhibiting Ras function and therefore inhibiting cellular growth is disclosed. The method comprises the administration of a compound of formula (1.0). Also disclosed are novel compounds of formulae (1.1, 1.2 and 1.3). Also disclosed are processes for making 3-substituted compounds of formulae (1.1, 1.2 and 1.3). Further disclosed are novel compounds which are intermediates in the processes for making the 3-substituted compounds of formulae (1.1, 1.2 and 1.3).
Patent IL-128218-A0 (IL)
Title: Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals
IPC: A61P31/12
Filed: 1997-08-01
Abstract: A flea infestation in the hair coat of a terrestrial mammal, notably dogs or cats, is controlled, eliminated or prevented by the systemic administration to the mammal of a 2,4-dienoic acid, salt or ester insecticide in an amount that is lethal to the fleas and/or their eggs, yet not sufficient to maintain a concentration of the insecticide in the host animal's blood that would be lethal to the fleas or their eggs if the fleas or eggs were fed exclusively and directly on the blood.
Patent IL-128851-A0 (IL)
Title: Medical treatment
IPC: A61K31/135
Filed: 1997-09-15
Abstract: PCT No. PCT/EP97/05034 Sec. 371 Date Mar. 25, 1999 Sec. 102(e) Date Mar. 25, 1999 PCT Filed Sep. 15, 1997 PCT Pub. No. WO98/13033 PCT Pub. Date Apr. 2, 1998A compound of formula I or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for lowering the uric acid level in humans, for example in humans suffering from or at risk of developing gout, hyperuricaemia or coronary heart disease.
Patent IL-131558-A0 (IL)
Title: Resonant antenna
IPC: H01Q9/04
Filed: 1998-02-24
Abstract: An antenna for receiving and transmitting electromagnetic microwaves having lambd wavelengths consisting of a substrate layer (10) made of a low dielectric material which bears on one side a conductive ground plane (1) and whose opposite side is conductively structured as micro-strip circuits. The conductive structure (S) has an elongate conductor section (3, 3a, 3b, R, Ra, Rb) which acts as a resonator and whose length (LR) is shorter than lambdc/4. One end of said conductor section is conductively connected to the ground plane (8, 1) and its other end is conductively connected to at least another conductor section (2, 2a, 2b, 4, 42a, 42b, 46a, 46b, K) used as an end capacitor to adjust resonance conditions. The conductor section (3, 3a, 3b, R, Ra, Rb) which acts as a resonator is connected to the inner conductor of a coaxial optical fiber and the outer conductor or the coaxial optical fiber is connected to the ground plane (1).
Patent IL-133815-A0 (IL)
Title: Process for the preparation of 2-alkylthiobenzonitrile derivatives
IPC: C07C319/14
Filed: 1998-07-03
Abstract: A process for preparing a compound of the formula:which comprises reacting a compound of the formula:wherein R3 is nitro or halo, with a compound of formula R1S-X wherein X is hydrogen or alkali metal.
Patent IL-141449-A0 (IL)
Title: Apparatus for dispensing pills, as well as dispenser and pillpack for use therein
IPC: B67B7/92
Filed: 1999-08-16
Abstract: In a pocket dispenser (1) for dispensing pills from a blister pack (2) to be placed in a ring shape, cavities (3) containing pills (P) are so distributed that the openings of the cavities therein are directed outwardly. The dispenser comprises a first part (5) for receiving the blister pack (2) in a ring shape, and a second part (6) fitting on said first part (5), which envelops the blister pack (2) together with the first part (5). The first part (5) and/or second part (6) comprise(s) at least one passage opening (7) with which a pill (P) to be dispensed can be aligned. A push-out means (8) includes an operating element (9), which can be positioned in line with the respective pills in the blister pack and with the passage opening (7) and which can be operated by said operating element (9) to move in at least substantially radial direction for pushing out the pill (P) to be dispensed through the passage opening (7). The operating element (9) is in the form of a pivoted push button, which is drivingly connected to the push-out means (8) which is slidably accommodated in a guide. The part (5) of the dispenser (1) that supports the operating element (9) includes means (20, 29) for imposing the pivoting movement. The push-out means (8) includes an ejector nose (32) having a sloping ejection surface (33), such that each cavity (3) is loaded off-center upon ejection of a pill (P). The blister pack (2) comprises means which are visible through said passage opening (7) for providing an indication as to the contents of the cavity in the blister pack that is positioned in line with the passage opening (7).
Patent IL-141884-A0 (IL)
Title: Method for fabricating composite pressure vessels and products fabricated by the method
IPC: B29C53/66
Filed: 1999-09-13
Abstract: A process for making a composite vessel includes the steps of: A) preforming a composite shell (63) for the vessel (for example, by winding fiberglass and a thermoplastic material onto a thermoplastic mandrel) which includes a thermoplastic film liner (66) sealing the interior surface thereof; B) in a mold (60) (which optionally may be heated), heating the composite shell and thermoplastic film liner while applying at least one force (9) (by, for example, evacuating the mold, pressurizing the thermoplastic film liner or both) which tends to urge the thermoplastic film liner and the composite shell outwardly; C) continuing step B) until the thermoplastic film liner and the composite shell consolidate and the exterior surface of the composite shell becomes fluid and flows to conform to the interior surface of the mold, thereby forming the composite vessel; D) allowing the formed composite vessel to cool; and E) removing the formed composite vessel from the mold. Suitable thermoplastic materials includes: polyethylene, polypropylene, polybutylene terephthalate and polyethylene terephthalate. The resulting composite vessel exhibits superior mechanical and aesthetic properties.
Patent IL-144402-A0 (IL)
Title: Identifying, monitoring, and treating women for breast precancer or cancer
IPC: A61K31/4196
Filed: 2000-01-25
Abstract: The invention provides devices, kits and methods for delivering an agent to a breast milk duct. Intraductal agent delivery provides an opportunity to treat a breast condition locally and avoid the pitfalls of systemic drug delivery for a local condition. Time-released agents delivered into the ducts using an intraductal device or formulation reduces the frequency of intraductal administration required for desired efficacy over time. The methods include methods of treating a breast condition, including the conditions of cancer or precancer.
Patent IL-150787-A0 (IL)
Title: Semi-synthetic taxanes with antitumor and antiangiogenetic activities
IPC: C07D305/08
Filed: 2001-01-15
Abstract: Seco-baccatin III derivatives of formula: wherein R, R<SUB>1</SUB>-R<SUB>4</SUB>, <?delete-start id="DEL-S-00001" date="20070710" ?>R<SUP>1</SUP><?delete-end id="DEL-S-00001" ?> <?insert-start id="INS-S-00001" date="20070710" ?>R'<?insert-end id="INS-S-00001" ?>, <?delete-start id="DEL-S-00002" date="20070710" ?>R<SUP>11</SUP><?delete-end id="DEL-S-00002" ?> <?insert-start id="INS-S-00002" date="20070710" ?>R''<?insert-end id="INS-S-00002" ?>, and <?delete-start id="DEL-S-00003" date="20070710" ?>R<SUP>111</SUP><?delete-end id="DEL-S-00003" ?> <?insert-start id="INS-S-00003" date="20070710" ?>R'''<?insert-end id="INS-S-00003" ?> are disclosed herein; pharmaceutical compositions comprising seco-baccatin III derivative; and methods for treating cancer, arthritis, and inhibiting angiogenesis in an animal comprising administrating to a patient in need thereof a therapeutically effective amount of a seco-baccatin III derivative are disclosed.
Patent IL-163754-A0 (IL)
Title: Plastic container
IPC: B65D1/12
Filed: 2003-04-23
Abstract: The invention relates to a multi-layer plastic container ( 10 ) for the storage and transport of materials in particular with an explosion risk, comprising at least two layers of plastic, whereby the inner layer ( 14 ) is not electrically conducting and the outer layer ( 12 ) is electrically conducting. According to the invention, an electrostatic charging of the plastic container or/and the inner filled material with a risk of explosion may be avoided, whereby a permanent electrical connection between the inner packed material and the base on which the plastic container ( 10 ) is mounted is provided which guarantees a secure discharge of electrostatic charging of the container body or the packed material to the base.
Patent IL-165390-A0 (IL)
Title: Methods for identifying and extracting endotoxin
IPC: B01J20/24
Filed: 2003-06-24
Abstract: The invention relates to a method for identifying endotoxins for eliminating said endotoxins from a sample, with the aid of bacteriophage tail proteins.
Patent IL-170743-A0 (IL)
Title: Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin
IPC: A61K31/445
Filed: 2005-09-08
Abstract: The use of 1-benzoyl-4-(((pyridin-2-ylmethyl)-amino)-methyl)-piperidine derivatives (I) for treating the symptoms of chronic pain of neuropathic or psychogenic origin is new. The use of pyridine derivatives of formula (I), or their mineral or organic acid addition salts, is claimed in the production of medicaments for treating the symptoms of chronic pain of neuropathic or psychogenic origin. [Image] U : H; or may also be Me if V = W = H; V : H or Cl; or may also be Me if U = W = H; W : H or F; or may also be Me if U = V = H; X : H or F; Y : Cl or Me; Z : H, F, Cl or Me; A : H, F, Cl, 1-5C alkyl, fluoroalkyl (e.g. CH 2F, CHF 2, CF 3, CHFMe or CF 2Me), 3-5C cycloalkyl, optionally substituted 5-membered aromatic heterocyclyl containing 1-4 of N, O and/or S as heteroatom(s) (provided that not more than one O and/or S is present), OR 1, SR 1, NR 2R 3, azetidino, pyrrolidino or alkoxycarbonyl (preferably COOMe or COOEt); R 11-5C alkyl, CH 2F, CF 3 or 3-5C cycloalkyl; R 2, R 3H, 1-5C alkyl, CF 3 or cyclopropyl. ACTIVITY : Analgesic. In tests for activity against central neuropathic pain induced by spinal column lesions in rats (see Pain, 1996, 66, 279-286), (3-chloro-4-fluorophenyl)-(4-fluoro-(((5-methyl-pyridin-2-ylmethyl)-amino)-methyl)-piperidin-1-yl)-methanone (Ia) was administered (as the fumarate) at a constant rate of 0.63 mg per day for 14 days using an implanted analgesic pump. Statistically significant analgesia was observed from day 10 of the treatment (demonstrating symptomatic analgesic action); and the analgesia remained at the same level from day 15 after cessation of the treatment for a further 14 days (demonstrating curative analgesic action). MECHANISM OF ACTION : 5-HT-1A receptor agonist.
Patent IL-194392-A0 (IL)
Title: Piperidine derivatives useful as serotonin transporter inhibitors and neurokinin-1 receptor antagonists
Filed: 2008-09-25
Abstract: The present invention relates to trans-derivatives of formula wherein R1, R2, R3, and the dotted line are as defined herein and to pharmaceutically acceptable acid addition salts thereof. The compounds of formula I are good inhibitors of the serotonin transporter (SERT inhibitors) and simultaneously, they have good activity on the NK-1 receptor (dual effect). By virtue of their efficacy as SERT inhibitors, the compounds in the present invention are particularly useful for the treatment of CNS disorders and psychotic disorders, in particular in the treatment or prevention of depressive states and/or in the treatment of anxiety.
Patent IL-195710-A0 (IL)
Title: Process for preparing spray dried formulations of tmc125
Filed: 2008-12-04
Abstract: This invention relates to a process for producing a spray-dried powder comprising microcrystalline cellulose in a solid dispersion of the anti-HIV compound etravirine (TMC125) in a water-soluble polymer.
Patent IL-196654-A0 (IL)
Title: Camptothecin derivatives with antitumor activity
Filed: 2009-01-22
Abstract: Novel camptothecin derivatives having antitumor activity, the processes for the preparation thereof, the use thereof as antitumor drugs and pharmaceutical compositions containing them.
Patent RO-134266-A0 (RO)
Title: Optimal control method for asynchronous traction motors of autonomous locomotives, based on controlling slip frequency
Inventor: POPESCU MIHAELA
IPC: H02P23/08
Filed: 2019-10-24
Abstract: The invention relates to a method for controlling asynchronous traction motors of autonomous locomotives. According to the invention, the method is based on the fact that, at any stationary point of operation of the asynchronous motor, there is an optimal value of the slip frequency which maximizes the efficiency of the motor and the dependence of the optimal slip frequency in relation to the speed, at constant current, is linear on two domains of the speed variation, on the fact that the dynamic acceleration or deceleration processes, with the accelerations required by the vehicle, are also obtained by controlling the rotor slip frequency, by forcing the optimal values corresponding to the stationary regime, also resulting in a linear variation, and on the modality to change the rotor slip frequency when switching from dynamic regime to stationary regime and vice versa, so that there are no impermissible dynamic shocks, the method comprising the decomposing of the transient mode into two stages: heavy transient mode, when the relative speed error (ε) exceeds an imposed limit (ε), and light transient mode, when the relative speed error is equal to or below the imposed limit.
Patent RO-135114-A0 (RO)
Title: Process for improving water quality by its purification
Inventor: BURLACU LEONARD
IPC: C02F1/22
Filed: 2021-03-11
Abstract: The invention relates to a process for purifying and improving water quality by a sequence of treatments and methods, in order to reduce or eliminate the concentration of deuterium in water. According to the invention, the process consists in decanting the suspensions from water in the presence of silver and silicon, filtering the water by any method and with any type of filter, boiling the water, lowering the water temperature or freezing it at a temperature between -1...1.8°C by using specific devices such as freezer, cooler, liquid nitrogen or in the atmosphere when outside temperatures drop below -1°C, the whole process being repeated once or several times, with or without substances, followed by filtration, to separate ice from water whenever necessary, all the above being done by the "cascade" method.
Patent RO-135874-A0 (RO)
Title: Device for inertially separating and sorting particles contained in a moving fluid
Inventor: MATEI DANIEL-ION
IPC: B04C5/081
Filed: 2022-03-04
Abstract: The invention relates to a device for the separation and continuous inertial sorting of particles from a moving fluid, the device being used as a fluid filtration system and for sorting suspended particles depending on their physical-mechanical characteristics. According to the invention, the device consists of a rectangular body (a), whose volume is limited by an outer housing (1), a main intake port (2) is provided at one of the ends of the body (a), said port being arranged so as to allow a fluid flow mixed with particles to be guided towards a first CDP plate (3) from a succession of three similar CDP plates (3) having an approximately rectangular shape with a slightly curved surface, each CDP plate being shaped in its terminal part as a flap (V), on the surface of which small grooves (s) alternating with projections (p) are profiled uniformly and parallely, with the role of guiding the moving fluid flow, the CDP plates (3) being arranged vertically and successively in the horizontally placed rectangular body (a), on its both vertical walls, at a distance between them which progressively decreases taking over the fluid from the main intake port (2) and directing it among the CDP plates (3), thereby forming between the adjacent plates some subzones (Zn) in which a vortex (Xn) is created, so that a succession of vortices (Xn) decreasing in size is formed between the CDP plates (3) starting from the main intake port (2), where, depending on its position in the rectangular body (a), a CDP plate may exhibit, in the continuation of the flap (V), a guide element (G) with a curved plane profile so arranged relative to the plane of the flap (V) to favor, according to the Coanda principle, a path of the fluid with particles above it and at the same time towards the entrance in the separation zone of the next vortex (V).
Patent MW-6891-A1 (MW)
Title: Inclusion complexes of 3-morpho-lino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same
IPC: C07D413/04
Filed: 1991-11-13
Abstract: PCT No. PCT/HU91/00013 Sec. 371 Date Jan. 2, 1992 Sec. 102(e) Date Jan. 2, 1992 PCT Filed Mar. 28, 1991.The invention relates to inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same. The inclusion complex of 3-morpholino-sydnonimine or its salt formed with cyclodextrin derivative is prepared by a) reacting the 3-morpholino-sydnonimine or its salt in an aqueous medium with a cyclodextrin derivative and the complex is isolated from the solution by dehydratation, or b) high energy milling of 3-morpholino-sydnonimine or its salt and a cyclodextrin derivative.
Patent MA-25029-A1 (MA)
Title: Formulations antiparasitaires contenant une avermectine ou milbemycine, et procede pour leur preparation.
Inventor: TIMOTHY MICHAEL LUKAS
IPC: A01N25/00
Filed: 1999-11-17
Abstract: L'INVENTION CONCERNE UNE ANTIPARASITAIRE POUR APPLICATION TOPIQUE,  COMPRENANT UNE AVERMECTINE,  UN ETHER DE MONO (ALKYKE EN C1 À C4 DE DI (GLYCOL EN C1 À C4),  UN ANTIOXYDANT FACULTATIF ET UN SOLVANT VOLATIL FACULTATIF.ELLE CONCERNE ÉGALEMENT UN PROCÉDÉ POUR SA PRÉPARATION. APPLICATION  :  UTILISATION DE CETTE FORMULATION POUR LE TRAITEMENT D'UNE AFFECTION PROVOQUÉE PAR UN ENDO- OU ECTO-PARASITE.
Patent MA-20150004-A1 (MA)
Title: Gestion de localisation, payement et approvisionnement des distributeur automatiques
Inventor: MOUNIR GHOGHO
IPC: G06Q20/00
Filed: 2013-06-06
Abstract: Notre invention concerne un distributeur automatique doté d'un système électronique-informatique qui permet sa gestion à distance par sms. Le système permet le payement des achats effectués par sms, sans avoir besoin de monnaie. Les distributeurs sont reliés par réseaux à des serveurs qui comptabiliseront la marchandise dedans. Ceci permettra d'optimiser les programmes d'interventions pour le ravitaillement des machines. Notre système permet la localisation du distributeurle plus proche et qui contient le bien désiré à tout client qui lance une requête de recherche. Chaque distributeur sera identifié par un id ainsi que les produits en vente. Le client envoi par sms les ids distributeur et produit à un serveur qui traitera les données en vérifiant la disponibilité du produit et du solde client. Le serveur actualise les données concernant les produits dans les distributeurs après chaque transaction et l'operateur déduit le prix du produit du solde téléphonique du client.
Patent MA-20150007-A1 (MA)
Inventor: BENALI ABDELLAH
IPC: B62B9/08
Filed: 2013-06-06
Abstract: يقدم هذا الإختراع عَرَبَةُ خفيفة لحمل الأطفال، مصنوعة من ٱلياف الكاربون او الالمنيوم تطوى بسهولة لتسهيل عملية حمل الأطفال، مجهزة بحامل للأطفال و الرضع، إن اهم ماجاءت به هذه العربة هو زر التشغيل و الكبح